Login to access your membership accounts, education training and products and services.
Online5/3/2017 - 5/24/2017
RAPS Virtual Career Fairs are designed to connect employees with employers no matter where they might be located.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Regulatory Exchange, aka RegEx, is where members come online to learn, grow and engage with a diverse global community of regulatory professionals with similar interests and goals.
It’s well-known that the National Institutes of Health (NIH) offers billions of dollars in grants to US academic research facilities. What’s less well-known is that each year, hundreds of new inventions are produced in the laboratories of NIH, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), and these inventions are licensed out to private companies in the US and internationally for further research and development, with the hopes of bringing new products to market.
This article discusses the difficulties encountered by medical personnel working with refugees in Syria and delivering pharmaceutical products. It describes relevant regulatory policy and guidance for drug procurement and quality.
Sen. Claire McCaskill (D-MO) late last week sent a letter to the CEO of Mallinckrodt seeking more information on price increases of its injectable version of acetaminophen as hospitals reported millions in increased costs.
The US Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) sent its first untitled letter of 2017 to Orexigen Therapeutics for a television ad that created a misleading impression about the safety of the weight loss drug Contrave (naltrexone HCl and bupropion HCl).
Get timely, relevant regulatory news, insight and information from Regulatory Focus
RAPS members enjoy in-depth perspectives on regulatory topics written by regulatory experts
Find out what's going on with your RAPS
RAPS conducts critical research that provides vital information and trends
Network with the regulatory community -- worldwide
Get the day's top regulatory headlines delivered right to your inbox
Press releases and contact information for the media
Collections and resources from Regulatory Focus